Systematic Comparison of Uremic Toxin Removal Using Different Hemodialysis Modes: A Single-Center Crossover...

Area of Science:

• Nephrology and Urology
• Renal Replacement Therapy
• Biomedical Engineering

Background:

• Hemodiafiltration (HDF) is hypothesized to improve patient outcomes compared to hemodialysis (HD) due to reduced intradialytic hypotension and enhanced toxin removal.
• Understanding the comparative efficacy of different HDF modalities in removing various uremic toxins is crucial for optimizing treatment strategies.

Purpose of the Study:

• To systematically analyze and compare the removal ratios of uremic toxins across three categories using hemodialysis (HD), online postdilution hemodiafiltration (postHDF), and online predilution hemodiafiltration (preHDF).
• To evaluate the impact of different extracorporeal therapies on the clearance of small, middle, and protein-bound uremic toxins.

Main Methods:

• A single-center, prospective, observational crossover study involving 26 patients undergoing three renal replacement therapies: HD, preHDF, and postHDF.
• Measurement of reduction ratios for uremic toxins categorized by the Eutox group, including beta2-microglobulin, myoglobin, kappa and lambda free light chains, and protein-bound solutes like PCS.
• Analysis included assessment of albumin loss and comparison of mean Kt/Vurea across treatment modalities.

Main Results:

• Hemodiafiltration significantly increased the reduction ratio of beta2-microglobulin compared to HD (p < 0.001).
• Both preHDF and postHDF demonstrated significantly higher reduction ratios for myoglobin, kappa, and lambda free light chains compared to HD (p < 0.001).
• While HDF improved the removal of middle molecules, no significant difference in indole concentration removal was observed between HD and HDF, irrespective of the synthetic dialysis membrane used. Albumin loss was minimal (< 2 g).

Conclusions:

• Online hemodiafiltration, both predilution and postdilution, offers superior removal of middle molecules compared to conventional hemodialysis.
• HDF demonstrates enhanced clearance of specific uremic toxins, potentially contributing to improved patient outcomes, although its effect on indoles is comparable to HD.
• The study highlights the benefits of HDF in managing middle molecule uremic toxins, with minimal impact on albumin levels.